Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Leydig cell tumor of the testis in tuberous sclerosis: lack of second hit events.

Leydig cell tumor of the testis in tuberous sclerosis: lack of second hit events. Oncologist. 2012; 17(7):927-9.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.